Danish pharmaceutical giant Novo Nordisk has officially launched its popular diabetes medication Ozempic in India. The lowest starting dose of 0.25 mg is priced at ₹2,200 per week, offering a new treatment option for millions of people with type 2 diabetes in the country.
📌 What is Ozempic?
· Generic Name: Semaglutide
· Purpose: Primarily used for managing type 2 diabetes and also effective in weight management for overweight or obese patients.
· Dosage: Administered once weekly via injection, with doses adjustable based on medical advice.
⚠️ Doctor’s Recommendations
1. Strict Adherence Required:
o Patients must follow the weekly regimen exactly as prescribed.
2. Lifestyle Integration:
o Doctors stress that dietary control, exercise, and regular monitoring remain essential alongside Ozempic.
3. Potential Side Effects:
o Mild side effects may include nausea, vomiting, or stomach discomfort.
o Regular follow-ups are advised to track effectiveness and manage adverse reactions.
4. Not a Replacement for Healthy Habits:
o Ozempic enhances diabetes and weight management but works best when combined with healthy eating and physical activity.
📌 Significance of the Launch in India
· Rising diabetes Rates: india has a large and growing population affected by type 2 diabetes, making new treatments crucial.
· Obesity Management: Ozempic provides additional support for weight loss, which is often linked to diabetes control.
· Weekly Convenience: The once-a-week injection is easier for patients to manage compared to daily medications.
💡 Final Thoughts
The availability of Ozempic in india is a significant development in diabetes care, offering patients an effective treatment for both blood sugar control and weight management. However, doctors caution that success depends on strict adherence to dosage and lifestyle modifications, making it important to consult a healthcare professional before starting therapy.
Disclaimer:
The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk..jpg)
click and follow Indiaherald WhatsApp channel